HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Huijuan Shi Selected Research

qigesan

1/2020Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal transition.
1/2019Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression.
1/2016Qigesan inhibits migration and invasion of esophageal cancer cells via inducing connexin expression and enhancing gap junction function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Huijuan Shi Research Topics

Disease

27Neoplasms (Cancer)
07/2022 - 07/2012
9Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 08/2013
8Carcinogenesis
01/2021 - 07/2012
7Neoplasm Metastasis (Metastasis)
01/2021 - 01/2011
5Colonic Neoplasms (Colon Cancer)
01/2020 - 01/2013
5Infertility (Sterility)
01/2019 - 09/2012
4Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 06/2017
4Breast Neoplasms (Breast Cancer)
01/2021 - 01/2018
3Carcinoma (Carcinomatosis)
07/2022 - 01/2014
3Stomach Neoplasms (Stomach Cancer)
01/2021 - 07/2015
3Ewing Sarcoma (Sarcoma, Ewing)
01/2021 - 11/2013
3Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 01/2016
3Male Infertility (Male Sterility)
12/2018 - 02/2015
3Inflammation (Inflammations)
01/2018 - 04/2013
2Hypogonadism (Hypergonadotropic Hypogonadism)
06/2021 - 01/2021
2Pancreatic Neoplasms (Pancreatic Cancer)
06/2020 - 09/2015
2Acute Lung Injury
01/2018 - 01/2018
2Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
07/2015 - 07/2010
2Septic Shock (Toxic Shock Syndrome)
07/2015 - 04/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2014 - 09/2014
2Uterine Cervical Dysplasia
10/2014 - 09/2014
1Disorders of Sex Development (Intersexuality)
06/2022
1Inborn Genetic Diseases (Disease, Hereditary)
06/2022
1Androgen-Insensitivity Syndrome (Testicular Feminization)
06/2022
1Lung Diseases (Lung Disease)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
06/2021
1Medically Unexplained Symptoms
06/2021
1Hyperthermia
01/2021
1Pruritus (Itching)
01/2020
1Eczema
01/2020
1Alopecia Areata
01/2020
1Sarcoma (Soft Tissue Sarcoma)
01/2019
1Pulmonary Edema
01/2018
1Chondroma (Enchondroma)
01/2018
1Chondrosarcoma
01/2018
1Lung Injury
01/2018

Drug/Important Bio-Agent (IBA)

8CateninsIBA
01/2018 - 01/2013
6MicroRNAs (MicroRNA)IBA
06/2021 - 10/2014
6Proteins (Proteins, Gene)FDA Link
01/2018 - 09/2012
5Biological ProductsIBA
01/2018 - 11/2013
4Long Noncoding RNAIBA
10/2021 - 01/2018
4hepatoma-derived growth factorIBA
01/2021 - 11/2013
3Biomarkers (Surrogate Marker)IBA
02/2022 - 02/2016
3Messenger RNA (mRNA)IBA
01/2021 - 11/2013
3qigesanIBA
01/2020 - 01/2016
2Small Interfering RNA (siRNA)IBA
07/2022 - 07/2012
2Androgen Receptors (Androgen Receptor)IBA
06/2022 - 01/2021
2Circular RNAIBA
01/2022 - 06/2020
2oxymatrineIBA
01/2022 - 06/2017
2RNA (Ribonucleic Acid)IBA
06/2021 - 01/2019
2Therapeutic UsesIBA
01/2021 - 04/2013
2EnzymesIBA
01/2020 - 12/2012
2Eosine Yellowish-(YS) (Eosin)IBA
01/2018 - 12/2012
2Beclin-1IBA
04/2016 - 09/2015
2VimentinIBA
01/2015 - 01/2014
2MART-1 AntigenIBA
01/2014 - 01/2014
2S100 Proteins (S 100 Protein)IBA
01/2014 - 01/2014
1Folic Acid (Vitamin M)FDA LinkGeneric
07/2022
1Biocompatible Materials (Biomaterials)IBA
07/2022
1Granzymes (Granzyme)IBA
07/2022
1DNA (Deoxyribonucleic Acid)IBA
07/2022
1Paclitaxel (Taxol)FDA LinkGeneric
10/2021
1Competitive Endogenous RNAIBA
06/2021
1Hormones (Hormone)IBA
06/2021
1Nicotinamide PhosphoribosyltransferaseIBA
03/2021
1Sex Hormone-Binding GlobulinIBA
01/2021
1LuciferasesIBA
01/2021
1Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
01/2021
1GTP Phosphohydrolases (GTPases)IBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Testosterone (Sustanon)FDA Link
01/2021
1human MIRN520 microRNAIBA
06/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1HexokinaseIBA
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020
1Immunoglobulin A (IgA)IBA
01/2020
1Untranslated RNA (Noncoding RNA)IBA
01/2020
1Glycyrrhizic Acid (Glycyrrhizin)IBA
01/2020
1human ERBB2 proteinIBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Cyclin D1IBA
01/2019
1Estrogen ReceptorsIBA
01/2019
1Progesterone Receptors (Progesterone Receptor)IBA
01/2019
1ChromatinIBA
01/2019
1Biological FactorsIBA
01/2019
1NicotineFDA Link
01/2019
1Pharmaceutical PreparationsIBA
12/2018
1LipoxinsIBA
01/2018
1methyl ester 5(S),6(R)-7-trihydroxyheptanoic acidIBA
01/2018
1Hematoxylin (Haematoxylon)IBA
01/2018

Therapy/Procedure

7Therapeutics
07/2022 - 01/2013
3Drug Therapy (Chemotherapy)
01/2020 - 01/2013
3Radiotherapy
01/2020 - 01/2011
2Aftercare (After-Treatment)
01/2022 - 11/2014
2Hyperthermic Intraperitoneal Chemotherapy
01/2021 - 07/2015
1Investigational Therapies (Experimental Therapy)
07/2022
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021
1Neoadjuvant Therapy
01/2021
1Induced Hyperthermia (Thermotherapy)
01/2021
1Segmental Mastectomy (Lumpectomy)
01/2021